CC
RXDX

Casdin Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Casdin Capital’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-150,000
Closed -$16.1M – 45
2023
Q1 		$16.1M Hold
150,000
– – 1.33% 24
2022
Q4 		$16.5M Buy
+150,000
New +$16.5M 1.28% 22